» Articles » PMID: 33584998

The Potentials of Probiotics on Gluten Hydrolysis; a Review Study

Overview
Specialty Gastroenterology
Date 2021 Feb 15
PMID 33584998
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Celiac disease (CD) is an autoimmune disorder of the small intestinal mucosa in genetically susceptible subjects consuming gluten. Gluten in wheat, rye and barley is harmful for some individuals and leads to various symptoms. Research has shown that treatment with probiotics in CD patients could improve the symptoms by the gluten hydrolysis. For this purpose, different databases such as Medline, PubMed, Scopus, and Google Scholar were searched using the following keywords: Celiac disease, Wheat flour, Gluten, glutamine, Probiotic, Bifidobacterium, Lactobacillus, Enzymes, Wheat allergy, Immune system, T cells, HLA-DQ2, HLA-DQ8, Gluten-free diet, Proteolysis, α2-gliadin fragment, Gliadin, 33-mer peptide, and Zonulin. The search aimed to retrieve the articles published during 2000-2019. Today, a gluten-free diet (GFD) is the only celiac disease treatment. Biotechnological strategy based on probiotic treatment could degrade gluten. Research has shown that combination of the probiotic enzyme is more effective than single probiotic on gluten hydrolysis. The result of different studies showed that probiotic mixture has the capacity to hydrolyze a considerable concentration of the 33-mer of gliadin completely. The present study was aimed to investigate associations between the capacities of probiotics on gluten hydrolysis.

Citing Articles

Intestinal permeability, food antigens and the microbiome: a multifaceted perspective.

Valitutti F, Mennini M, Monacelli G, Fagiolari G, Piccirillo M, Di Nardo G Front Allergy. 2025; 5():1505834.

PMID: 39850945 PMC: 11754301. DOI: 10.3389/falgy.2024.1505834.


Assessment of salivary microbiota profile as a potential diagnostic tool for pediatric celiac disease.

Noruzpour A, Gholam-Mostafaei F, Azizmohammad Looha M, Dabiri H, Ahmadipour S, Rouhani P Sci Rep. 2024; 14(1):16712.

PMID: 39030381 PMC: 11271620. DOI: 10.1038/s41598-024-67677-4.


The Gliadin Hydrolysis Capacity of , , and and Their Protective Effects on Caco-2 Cells against Gliadin-Induced Inflammatory Responses.

Ramedani N, Seidita A, Asri N, Azimirad M, Yadegar A, Jahani-Sherafat S Nutrients. 2023; 15(12).

PMID: 37375673 PMC: 10301210. DOI: 10.3390/nu15122769.


New Insights into Non-Dietary Treatment in Celiac Disease: Emerging Therapeutic Options.

Segura V, Ruiz-Carnicer A, Sousa C, Moreno M Nutrients. 2021; 13(7).

PMID: 34201435 PMC: 8308370. DOI: 10.3390/nu13072146.

References
1.
Ehren J, Moron B, Martin E, Bethune M, Gray G, Khosla C . A food-grade enzyme preparation with modest gluten detoxification properties. PLoS One. 2009; 4(7):e6313. PMC: 2708912. DOI: 10.1371/journal.pone.0006313. View

2.
Sahebekhtiari N, Nochi Z, Eslampour M, Dabiri H, Bolfion M, Taherikalani M . Characterization of Staphylococcus aureus strains isolated from raw milk of bovine subclinical mastitis in Tehran and Mashhad. Acta Microbiol Immunol Hung. 2011; 58(2):113-21. DOI: 10.1556/AMicr.58.2011.2.4. View

3.
Lukic J, Chen V, Strahinic I, Begovic J, Lev-Tov H, Davis S . Probiotics or pro-healers: the role of beneficial bacteria in tissue repair. Wound Repair Regen. 2018; 25(6):912-922. PMC: 5854537. DOI: 10.1111/wrr.12607. View

4.
Boyce J, Assaad A, Burks A, Jones S, Sampson H, Wood R . Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010; 126(6 Suppl):S1-58. PMC: 4241964. DOI: 10.1016/j.jaci.2010.10.007. View

5.
Bascunan K, Araya M, Roncoroni L, Doneda L, Elli L . Dietary Gluten as a Conditioning Factor of the Gut Microbiota in Celiac Disease. Adv Nutr. 2019; 11(1):160-174. PMC: 7442381. DOI: 10.1093/advances/nmz080. View